These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36912400)

  • 1. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
    Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
    Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic properties in functional connectivity changes and striatal dopamine deficiency in Parkinson's disease.
    Asendorf AL; Theis H; Tittgemeyer M; Timmermann L; Fink GR; Drzezga A; Eggers C; Ruppert-Junck MC; Pedrosa DJ; Hoenig MC; van Eimeren T
    Hum Brain Mapp; 2024 Jul; 45(10):e26776. PubMed ID: 38958131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study.
    Koros C; Simitsi AM; Prentakis A; Papagiannakis N; Bougea A; Pachi I; Papadimitriou D; Beratis I; Papageorgiou SG; Stamelou M; Trapali XG; Stefanis L
    Parkinsonism Relat Disord; 2020 Aug; 77():36-42. PubMed ID: 32615498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis.
    Lee JY; Lao-Kaim NP; Pasquini J; Deuschl G; Pavese N; Piccini P
    Parkinsonism Relat Disord; 2018 Jun; 51():101-104. PubMed ID: 29503156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts.
    Khosousi S; Sturchio A; Appleton E; Paslawski W; Ta M; Nalls M; Singleton AB; Iwaki H; Svenningsson P
    Mov Disord; 2024 Oct; 39(10):1881-1885. PubMed ID: 38798037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease.
    Pak K; Shin HK; Kim EJ; Lee JH; Lyoo CH; Son J; Lee MJ
    Parkinsonism Relat Disord; 2018 Jun; 51():67-72. PubMed ID: 29510907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease.
    Murtomäki K; Mertsalmi T; Jaakkola E; Mäkinen E; Levo R; Nojonen T; Eklund M; Nuuttila S; Lindholm K; Pekkonen E; Joutsa J; Noponen T; Ihalainen T; Kaasinen V; Scheperjans F
    Mov Disord; 2022 Jun; 37(6):1284-1289. PubMed ID: 35274368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
    Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
    BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrastriatal
    Nicastro N; Garibotto V; Burkhard PR
    BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic Correlates of Orthostatic Hypotension in de novo Parkinson's Disease.
    Umehara T; Oka H; Nakahara A; Shiraishi T; Sato T; Matsuno H; Komatsu T; Omoto S; Murakami H; Iguchi Y
    J Parkinsons Dis; 2021; 11(2):665-673. PubMed ID: 33361609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine Transporter Availability in Early Parkinson's Disease is Dependent on Sunlight Exposure.
    Booij J; Tellier SP; Seibyl J; Vriend C
    Mov Disord; 2023 Nov; 38(11):2131-2135. PubMed ID: 37670567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
    Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
    Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
    Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
    Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.